Press Release Capricor Therapeutics Announces Extension of PDUFA Target Action Date as FDA Continues Review of Deramiocel BLA 4 hours ago
Press Release Capricor Therapeutics Reports Second Quarter 2026 Financial Results and Provides Corporate Update Aug 13